It is proposed to consider limiting or avoiding high doses of THC in patients with positive family histories of psychosis; in situations of increased risk, targeted testing for AKT1 rs2494732 may be useful (clinical evidence of G×E) [10]. The gene discussed is AKT1; the disease is psychotic disorder.